Certara Investor Relations Material

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Established in 1997, Certara empowers customers to make better decisions with science-driven guidance across a breadth of therapeutic areas including cardiovascular, oncology, central nervous system disorders and rare diseases. Certara's solutions are used by top pharmaceutical companies around the world including Merck & Co., Inc., Pfizer Inc., Novartis AG and Johnson & Johnson Services Inc. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.